Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SeV-G(NP)
- Development stage
- Phase 1
- Lead developer
- International AIDS Vaccine Initiative
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intranasal
01
Overview
SeV-G(NP) is an investigational intranasal HIV vaccine candidate based on a recombinant Sendai virus vector. It is designed to express the HIV-1 Gag and Pol proteins (NP refers to nucleoprotein), aiming to stimulate both mucosal and systemic immune responses against HIV. The vaccine was developed as part of a prime-boost regimen, where it is administered intranasally followed by an intramuscular Ad35-GRIN boost. Its mechanism involves immunostimulation through delivery of viral antigens via a live attenuated viral vector, with the goal of inducing robust cellular and humoral immunity against HIV. The primary developer is the International AIDS Vaccine Initiative in collaboration with Id Pharma[1].
- Other names
- Sendai HIV vaccine SeV-G(NP)
02
Targets
TLR7/8 (Toll-like receptor 7 and Toll-like receptor 8)TLR3 (Toll-like receptor 3)
Beyond the preview
Go deeper on SeV-G(NP).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SeV-G(NP).